Seasonal Influenza Vaccination Market in Lithuania, Estonia, Latvia (Baltic Countries) By (Child & Adult) Forecast report published by Renub Research. According to this report, in the Baltic Countries, Lithuania is having the highest seasonal influenza vaccine market share followed by Latvia and Estonia. In terms of children vaccination, Lithuania & Latvia hold nearly 70 percent market share in 2016 whereas, in adult vaccination segments, these two will share more than 95 percent market share by 2022.
This report provides a complete analysis of 3 Baltic Countries (Lithuania, Estonia, Latvia) Seasonal Influenza Vaccine Market (Child & Adult), Number of Vaccinated Population (Child & Adult) and Forecast till 2022. All the 3 countries in the report have been studied from 2 viewpoints.
1. Seasonal Influenza Vaccine Market in Baltic Countries (2011 - 2022)
Seasonal Influenza Vaccine Market & Forecast
Children Seasonal Influenza Vaccine Market & Forecast
Adult Seasonal Influenza Vaccine Market & Forecast
2. Seasonal Influenza Vaccinated Population in Baltic Countries (2011 - 2022)
Seasonal Influenza Vaccinated Population & Forecast
Children Seasonal Influenza Vaccinated Population & Forecast
Adult Seasonal Influenza Vaccinated Population & Forecast
Countries studied in the report are as follows
Lithuania
Estonia
Latvia
Seasonal Influenza Vaccination Market in Lithuania, Estonia, Latvia (Baltic Countries) By (Child & Adult) Forecast
Table of Contents
1. Executive Summary
2. Baltic Countries Seasonal Influenza Vaccinated Population
2.1 Seasonal Influenza Vaccinated Child Population in Baltic Countries
2.2 Baltic Countries Seasonal Influenza Vaccinated Adult Population
3. Baltic Countries Seasonal Influenza Vaccine Market
3.1 Seasonal Influenza Child Vaccine Market in Baltic Countries
3.2 Seasonal Influenza Adult Vaccine Market in Baltic Countries
4. Baltic Countries Seasonal Influenza Vaccine Market Share Analysis
4.1 Seasonal Influenza Vaccine Market Share
4.2 Seasonal Influenza Child Vaccine Market Share
4.3 Baltic Countries - Seasonal Influenza Adult Vaccine Market Share
5. Estonia
5.1 Estonia Seasonal Influenza Vaccinated Population Analysis
5.1.1 Estonia Seasonal Influenza Vaccinated Population
5.1.2 Estonia Seasonal Influenza Vaccinated Child Population
5.1.3 Estonia Seasonal Influenza Vaccinated Adult Population
5.2 Estonia Seasonal Influenza Vaccine Market Analysis
5.2.1 Estonia Seasonal Influenza Vaccine Market
5.2.2 Estonia Seasonal Influenza Child Vaccine Market
5.2.3 Estonia Seasonal Influenza Adult Vaccine Market
6. Latvia
6.1 Latvia Seasonal Influenza Vaccinated Population Analysis
6.1.1 Latvia Seasonal Influenza Vaccinated Population
6.1.2 Latvia Seasonal Influenza Vaccinated Child Population
6.1.3 Latvia Seasonal Influenza Vaccinated Adult Population
6.2 Latvia Seasonal Influenza Vaccine Market Analysis
6.2.1 Latvia Seasonal Influenza Vaccine Market
6.2.2 Latvia Seasonal Influenza Child Vaccine Market
6.2.3 Latvia Seasonal Influenza Adult Vaccine Market
7. Lithuania
7.1 Lithuania Seasonal Influenza Vaccinated Population Analysis
7.1.1 Lithuania Seasonal Influenza Vaccinated Population
7.1.2 Lithuania Seasonal Influenza Vaccinated Child Population
7.1.3 Lithuania Seasonal Influenza Vaccinated Adult Population
7.2 Lithuania Seasonal Influenza Vaccine Market Analysis
7.2.1 Lithuania Seasonal Influenza Vaccine Market
7.2.2 Lithuania Seasonal Influenza Child Vaccine Market
7.2.3 Lithuania Seasonal Influenza Adult Vaccine Market
8. Seasonal Influenza Vaccine - Growth Drivers
8.1 Vaccine Manufacturers Plan to Increase Flu Vaccine Production
8.2 Growing Children & Ageing Population in Baltic Region
8.3 Rising Healthcare Expenditure Share of the Baltic Countries GDP
9. Seasonal Influenza Vaccine - Challenges
9.1 Regulatory Challenges with New and Novel Influenza Vaccines
9.2 Lack of Healthcare Infrastructure
9.3 Limited Reimbursement and Access to the Vaccines
List of Table:
Table 8 1: Baltic Countries - Healthcare Expenditure Share (Percent) of GDP, 2005 - 2015
List of Figures
:
Figure 2 1: Baltic Countries - Seasonal Influenza Vaccinated Population (Thousand), 2011 - 2016
Figure 2 2: Baltic Countries - Forecast for Seasonal Influenza Vaccinated Population (Thousand), 2017 - 2022
Figure 2 3: Baltic Countries - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 2 4: Baltic Countries - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 2 5: Baltic Countries - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 2 6: Baltic Countries - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 3 1: Baltic Countries - Seasonal Influenza Vaccine Market (Thousand), 2011 - 2016
Figure 3 2: Baltic Countries - Forecast for Seasonal Influenza Vaccine Market (Thousand), 2017 - 2022
Figure 3 3: Baltic Countries - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
Figure 3 4: Baltic Countries - Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
Figure 3 5: Baltic Countries - Seasonal Influenza Adult Vaccine Market (Thousand), 2011 - 2016
Figure 3 6: Baltic Countries - Forecast for Seasonal Influenza Adult Vaccine Market (Thousand), 2017 - 2022
Figure 4 1: Baltic Countries - Seasonal Influenza Vaccine Market Share (Percent), 2011 - 2016
Figure 4 2: Baltic Countries - Forecast for Seasonal Influenza Vaccine Market Share (Percent), 2017 - 2022
Figure 4 3: Baltic Countries - Seasonal Influenza Child Vaccine Market Share (Percent), 2011 - 2016
Figure 4 4: Baltic Countries - Forecast for Seasonal Influenza Child Vaccine Market Share (Percent), 2017 - 2022
Figure 4 5: Baltic Countries - Seasonal Influenza Adult Vaccine Market Share (Percent), 2011 - 2016
Figure 4 6: Baltic Countries - Forecast for Seasonal Influenza Adult Vaccine Market Share (Percent), 2017 - 2022
Figure 5 1: Estonia - Seasonal Influenza Vaccinated Population (Thousand), 2011 - 2016
Figure 5 2: Estonia -Forecast for Seasonal Influenza Vaccinated Population (Thousand), 2017 - 2022
Figure 5 3: Estonia- Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 5 4: Estonia- Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 5 5: Estonia - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 5 6: Estonia - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 5 7: Estonia- Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 5 8: Estonia- Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
Figure 5 9: Estonia - Seasonal Influenza Children Vaccine Market (Thousand US$), 2011 - 2016
Figure 5 10: Estonia - Forecast for Seasonal Influenza Children Vaccine Market (Thousand US$), 2017 - 2022
Figure 5 11: Estonia - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
Figure 5 12: Estonia - Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
Figure 6 1: Latvia - Seasonal Influenza Vaccinated Population (Thousand), 2011 - 2016
Figure 6 2: Latvia - Forecast for Seasonal Influenza Vaccinated Population (Thousand), 2017 - 2022
Figure 6 3: Latvia - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 6 4: Latvia - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 6 5: Latvia - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 6 6: Latvia - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 6 7: Latvia- Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 6 8: Latvia- Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
Figure 6 9: Latvia- Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
Figure 6 10: Latvia- Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
Figure 7 1: Lithuania - Seasonal Influenza Vaccinated Population (Thousand), 2011 - 2016
Figure 7 2: Lithuania - Forecast for Seasonal Influenza Vaccinated Population (Thousand), 2017 - 2022
Figure 7 3: Lithuania - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 7 4: Lithuania - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 7 5: Lithuania - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 7 6: Lithuania - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 7 7: Lithuania - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 7 8: Lithuania - Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 7 9: Lithuania - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
Figure 7 10: Lithuania - Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
Figure 7 11: Lithuania - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
Figure 7 12: Lithuania - Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
Figure 8 1: Vaccine Manufacturers - Influenza Vaccine Production (Million Doses), 2013-2015
Figure 8 2: Baltic Countries - Children Population (Thousand), 2010 - 2016
Figure 8 3: Baltic Countries - Forecast for Children Population (Thousand), 2017 - 2022
Figure 8 4: Baltic Countries - Ageing Population (Thousand), 2010 - 2016
Figure 8 5: Baltic Countries - Forecast for Ageing Population (Thousand), 2017 - 2022
Figure 9 1: Worldwide - Hospital Beds (Number) per Thousand, 2014 - 2019
Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 87
The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030.
North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
Global Esomeprazole Magnesium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 74
The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030.
North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
Global Combination Therapy Drug Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
Global Axitinib Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 68
The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
Global Lyme Disease Vaccine Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 70
The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi.
The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at......
Global Transdermal Absorption Patch Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
Global Ketoprofen Patches Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 78
Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis
The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
Global Methyl Salicylate Patches Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 82
The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
Global Diclofenac Patches Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 94
The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
